Associations with tumor features were examined, and protein expression of β-catenin, c-MYC and EpCAM were evaluated after miR-26a-5p modulation.<h4>Results</h4>Integrative bioinformatics identified miR-26a-5p as a candidate prognostic indicator for metabolic liver disease progression. This evidence concerns the gene EPCAM and neoplasm.